point-of-care molecular diagnostics

AmplifiDx is developing point-of-need molecular diagnostics for sexual health and family & women's health. Its DX 100 Platform is designed to provide fast, accurate, and reliable results with less than one minute of hands-on time and can detect up to 10 analytes. The company aims to combat the spread of infectious diseases by enabling global access to fast, accurate, and simple point-of-care testing.

multiplex testing

Diagnostics for the Real World (DRW) was established in 2003 as a spin-out from the Diagnostics Development Unit at the University of Cambridge. DRW develops point-of-care (POC) molecular diagnostics for serious infectious diseases, including its SAMBA platform for rapid, reliable testing in remote and resource-limited settings.

decentralised molecular testingrapid molecular testing

Krishi develops and commercializes point-of-care molecular diagnostics for Animal Health and Agriculture markets. Its Sherpa antibiotic guidance enables targeted antibiotic treatment of urinary tract or skin infections in dogs and cats within one hour, using a reusable IoT-connected heater and imager with a consumable test chip containing embedded reagents. The company also offers rapid detection of RNA and DNA targets with results in under an hour.

antibiotic guidance testingrapid RNA & DNA target detection